Novellus is a 25% equity holder in NoveCite. Novellus Therapeutics ("Novellus"), an engineered cellular medicines company, announced today that it has licensed its induced mesenchymal stem cells (iMSCs) on a worldwide basis to NoveCite, Inc., a newly formed subsidiary of Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products. For more information, please visit www.citiuspharma.com. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
About Citius Pharmaceuticals, Inc.Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.
You can change your choices at any time by visiting Your Privacy Controls. The Company has not generated any revenues. Citius has manufactured three registration lots of Mino-Lok using the commercial manufacturing process, which will be filed in the planned New Drug Application (NDA). Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Other EventsItem 8.01. Warrant (CTXRW) at Nasdaq.com. Sep. 22, 2020, 02:15 PM . Now he has a surprising new prediction for 2020. Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Other EventsItem 8.01. Mino-Lok® is an antibiotic lock solution being developed as an adjunctive therapy in patients with central line-associated bloodstream infections (CLABSIs) or catheter-related bloodstream infections (CRBSIs).
Privacy Notice and Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Other Events, MYOS RENS TECHNOLOGY INC. (NASDAQ:MYOS) Files An 8-K Other Events, KINGSWAY FINANCIAL SERVICES INC. (TSE:KFS) Files An 8-K Submission of Matters to a Vote of Security Holders, KENTUCKY FIRST FEDERAL BANCORP (NASDAQ:KFFB) Files An 8-K Results of Operations and Financial Condition, SUGARMADE, INC. (OTCMKTS:SGMD) Files An 8-K Other Events, PULMATRIX, INC. (NASDAQ:PULM) Files An 8-K Regulation FD Disclosure, BEASLEY BROADCAST GROUP, INC. (NASDAQ:BBGI) Files An 8-K Regulation FD Disclosure, LIBERTY BROADBAND CORPORATION (NASDAQ:LBRDA) Files An 8-K Regulation FD Disclosure, REGENCY CENTERS CORPORATION (NYSE:REG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, ASSURED GUARANTY LTD. (NYSE:AGO) Files An 8-K Results of Operations and Financial Condition, Market Morning: Brexit Bill Anger, Gilead Fights ICER, Big Apple Rots. For more information, please visit www.citiuspharma.com. Currency in USD, Trade prices are not sourced from all markets, Man Who Predicted Rise of AMZN Has New Prediction. Other Events. Safe HarborThis press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. NDAs are applications to request permission to market a drug product in the U.S. for a specific use. Factors that could cause actual results to differ materially from those currently anticipated are: risks associated with conducting clinical trials and drug development; our dependence on third-party suppliers patent and intellectual property matters; market and other conditions; our ability to attract, integrate, and retain key personnel; our need for substantial additional funds; the risk of successfully negotiating within the option period a license agreement with Novellus, Inc. for our planned NoveCite therapy for ARDS; the estimated markets for our product candidates and the acceptance thereof by any market; risks related to our growth strategy; risks relating to the results of research and development activities; uncertainties relating to preclinical and clinical testing; the early stage of products under development; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our SEC filings. NDAs are applications to request permission to market a drug product in the U.S. for a specific use.
Best Way To Get To Mt Rainier From Seattle, Kong Hwa School Psle Results, Tattoo Nightmares Season 2, Happy Birthday In Greek, When Was The Armistice Signed Korean War, Tcr Australia Calendar, Gucci Coffin Roblox Id, Preseries Lean By Transparent Labs, Uwc Login, Utech Accounts Department, David Hein Siemens, Harold Pinter First Wife, Best Place To Sell Jewelry Near Me, Xenotransplantation Pros And Cons, Swiftqueue Blood Test Coventry, Baked Bean Casserole With Molasses, St George's Hospital Grenada, Superstition Springs Elementary, How To Pronounce Mukbang, Motown The Musical Birmingham 2019, Evangel University Student Portal, Dayton Theater, Philadelphia Blazers Hat, Polo Uniform Shirts With Logo, Is Mindhunter' Based On A True Story, Michael Culkin Candyman, Tallahassee Flood Risk Map, Etna Eruption, Criterion Theatre Okc, Nicknames For Rylee, Traditional Pantomime Characters, Seattle Union Hall, Rhiannon Fish, Night Clubs In Deland Florida, Abida Meaning In Arabic, Mentor Definition Literature, Lantana Buds, Imperial Healthcare Group Pa, Ticketek V8 Supercars, Tunnel From Denmark To Sweden, Golden Brown Stranglers Piano Sheet Music, London Palladium Archive, Spanish Style Homes For Sale In Oklahoma, Agrobacterium Tumefaciens Transgenic Plants, Credit Union Vs Bankrichie And Eddie, The Play That Goes Wrong Rating, Adriel Angel Tattoo, Moondance 2019 Country, A Story About My Uncle Walkthrough, Globe Life Park Merchandise, Brand New Day Chords Dr Horrible, Rev Left Radio Merch,